Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022).

Matteo Boattini,Gabriele Bianco,Paulo Bastos,Sara Comini,Silvia Corcione,André Almeida,Cristina Costa,Francesco Giuseppe De Rosa,Rossana Cavallo

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology（2023）

引用 0|浏览3

暂无评分

摘要

Ceftazidime/avibactam resistance in KPC-Kp BSI easily emerged in our highly KPC-Kp endemic area with remarkable mortality rates. Our findings might provide physicians possibly actionable information when managing patients with a ceftazidime/avibactam-resistant KPC-Kp BSI.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要